Cargando…

Sepsis outcomes in patients with pre-existing liver disease

AIM OF THE STUDY: To determine the characteristics, including the use of various diagnostic criteria, outcomes and treatment strategies in septic patients treated outside of the critical care area with pre-existing liver disease (LD). MATERIAL AND METHODS: The study population included patients recr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kopczynska, Maja, Szakmany, Tamas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977879/
https://www.ncbi.nlm.nih.gov/pubmed/35402727
http://dx.doi.org/10.5114/ceh.2021.111421
_version_ 1784680860980609024
author Kopczynska, Maja
Szakmany, Tamas
author_facet Kopczynska, Maja
Szakmany, Tamas
author_sort Kopczynska, Maja
collection PubMed
description AIM OF THE STUDY: To determine the characteristics, including the use of various diagnostic criteria, outcomes and treatment strategies in septic patients treated outside of the critical care area with pre-existing liver disease (LD). MATERIAL AND METHODS: The study population included patients recruited into two annual 24-hour prospective point-prevalence studies on the general wards and emergency departments across all Welsh acute hospitals in 2016 and 2017. Data were collected on patient demographics, observations and SIRS, SOFA and qSOFA scores. RESULTS: Out of 839 recruited patients, 24 (2.9%) had a past medical history of LD. 12/24 (50%) had a SIRS score ≥ 2, 21/24 (87.5%) a SOFA score ≥ 2 and 3/24 (12.5%) a qSOFA score ≥ 2. Patients with LD had 2.4 times higher odds (95% CI = 1.07-5.53, p = 0.03) of mortality after the sepsis episode. LD patients were younger than non-LD patients (p = 0.04) but not significantly different in frailty, do not attempt cardiopulmonary resuscitation (DNA-CPR) status or ceiling of care (p = 0.78, p = 0.54, p = 0.06, respectively). CONCLUSIONS: The 90-day mortality was greater in patients with LD than the rest of the population. Management of sepsis in LD patients poses a challenge with current therapeutic bundles being underused and of unclear significance in improving patient outcome.
format Online
Article
Text
id pubmed-8977879
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-89778792022-04-07 Sepsis outcomes in patients with pre-existing liver disease Kopczynska, Maja Szakmany, Tamas Clin Exp Hepatol Original Paper AIM OF THE STUDY: To determine the characteristics, including the use of various diagnostic criteria, outcomes and treatment strategies in septic patients treated outside of the critical care area with pre-existing liver disease (LD). MATERIAL AND METHODS: The study population included patients recruited into two annual 24-hour prospective point-prevalence studies on the general wards and emergency departments across all Welsh acute hospitals in 2016 and 2017. Data were collected on patient demographics, observations and SIRS, SOFA and qSOFA scores. RESULTS: Out of 839 recruited patients, 24 (2.9%) had a past medical history of LD. 12/24 (50%) had a SIRS score ≥ 2, 21/24 (87.5%) a SOFA score ≥ 2 and 3/24 (12.5%) a qSOFA score ≥ 2. Patients with LD had 2.4 times higher odds (95% CI = 1.07-5.53, p = 0.03) of mortality after the sepsis episode. LD patients were younger than non-LD patients (p = 0.04) but not significantly different in frailty, do not attempt cardiopulmonary resuscitation (DNA-CPR) status or ceiling of care (p = 0.78, p = 0.54, p = 0.06, respectively). CONCLUSIONS: The 90-day mortality was greater in patients with LD than the rest of the population. Management of sepsis in LD patients poses a challenge with current therapeutic bundles being underused and of unclear significance in improving patient outcome. Termedia Publishing House 2021-12-10 2021-12 /pmc/articles/PMC8977879/ /pubmed/35402727 http://dx.doi.org/10.5114/ceh.2021.111421 Text en Copyright © 2021 Clinical and Experimental Hepatology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) )
spellingShingle Original Paper
Kopczynska, Maja
Szakmany, Tamas
Sepsis outcomes in patients with pre-existing liver disease
title Sepsis outcomes in patients with pre-existing liver disease
title_full Sepsis outcomes in patients with pre-existing liver disease
title_fullStr Sepsis outcomes in patients with pre-existing liver disease
title_full_unstemmed Sepsis outcomes in patients with pre-existing liver disease
title_short Sepsis outcomes in patients with pre-existing liver disease
title_sort sepsis outcomes in patients with pre-existing liver disease
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977879/
https://www.ncbi.nlm.nih.gov/pubmed/35402727
http://dx.doi.org/10.5114/ceh.2021.111421
work_keys_str_mv AT kopczynskamaja sepsisoutcomesinpatientswithpreexistingliverdisease
AT szakmanytamas sepsisoutcomesinpatientswithpreexistingliverdisease